When a company delivers a blockbuster quarter yet suffers the largest one-day share price collapse in its history, I instinctively wonder whether the market has become more emotional than analytical. That is precisely where Reddit finds itself. The company reported an exceptional second quarter, comfortably beating expectations on both revenue and earnings, only for investors to focus almost exclusively on one uncomfortable admission: Google's AI-powered search is changing how people find Reddit. Suddenly, Wall Street has split into two camps. One sees an overreaction to a temporary headwind. The other sees the first crack in the foundations of a premium growth stock. Both arguments deserve to be heard. When direction changes faster than fundamentals A Quarter That Should Have Been a Victo

The $1 Trillion Question: Did Wall Street Misread the Memory Crash? If there is one lesson I keep relearning in semiconductor investing, it is that the market has the memory of a goldfish until it suddenly remembers it is dealing with the memory industry. That is precisely what has happened to SK Hynix. Only weeks after completing the largest first-time US listing ever by a foreign company, with a Nasdaq ADR valued at roughly US$28–29 billion, the company found itself caught in one of the sharpest sentiment reversals of the AI era. A stock that had climbed roughly 220% before its July peak abruptly lost around 35%, joining a wider sell-off across $Micron Technology(MU)$, Samsung and $SanDisk Corp.(SNDK)$ as

Corning has survived world wars, recessions, technological revolutions and the collapse of entire industries. Yet one of the oldest companies on the New York Stock Exchange has just experienced its sharpest one-day share price fall since 30 July 2002—not because it missed earnings, but because it wasn't quite optimistic enough. That alone tells me everything about today's market. $Corning(GLW)$ delivered another strong quarter, with core earnings per share climbing 30% and comfortably beating expectations. The problem wasn't what the company achieved. It was what management expected next. Revenue guidance of $4.9-$5.0 billion landed fractionally below the market's expectation of around $5 billion, and investors wasted little time reminding everyone

Wall Street rarely admits it has no idea what a company is worth. Oklo is the exception. When analysts can justify price targets ranging from $14 to $140, they are not debating valuation models; they are debating reality. Either $Oklo Inc.(OKLO)$ evolves into the first successful commercial small modular reactor (SMR) developer of its kind, or it becomes another ambitious engineering story that never quite reaches escape velocity. The disagreement isn't confined to research notes. Oklo's shares surged to around $175 on a closing basis, while briefly touching almost $200 intraday last October, before suffering a sharp reset this year, illustrating just how quickly sentiment can swing when expectations run ahead of execution. At the same time, rough

The $267 Argument Isn't About AI – It's About Who Gets Paid CoreWeave isn't divided by opinion — it's divided by $267. That's the gap between Wall Street's lowest published price target of $36 and its highest of $303. When professionals studying the same filings arrive at valuations separated by nearly three hundred dollars, investors should pay attention. One company. Two futures. Wall Street cannot agree That extraordinary spread tells me this isn't a debate over whether artificial intelligence is real. It plainly is. The real argument is whether a specialist GPU cloud provider can generate attractive long-term returns while spending money at a pace that would make even the largest industrial companies pause for breath. This is why $CoreWeave, Inc.(

When unanimous optimism meets relentless scepticism When all 11 Wall Street analysts covering a stock rate it a Buy, you might expect investors to be piling in. Instead, $APPLIED DIGITAL CORP(APLD)$ has roughly 27% of its shares sold short, and after tumbling to around $30, even the most conservative analyst price target of $40 still implies roughly 33% upside. Either somebody is spectacularly wrong, or the market is seeing something the analysts aren't. One company. Two futures. One extraordinary disagreement That extraordinary disconnect makes Applied Digital one of the most fascinating battleground stocks in AI infrastructure today. This isn't the usual debate over whether artificial intelligence will change the world. Most investors agree it w

One share price, two completely different stories I rarely see a stock where Wall Street and the market appear to be reading entirely different scripts. Hims & Hers Health trades around $33, yet the consensus target from 13 analysts sits between $28 and $30, implying roughly 13% downside. At the bullish end, Canaccord Genuity recently lifted its target to $40. At the bearish end, one analyst believes the shares are worth just $21. That's a spread of more than 90% between the highest and lowest targets, and it tells me one thing above all else: nobody can agree what this business is actually worth. The market and Wall Street rarely disagree this dramatically. Perhaps the market still knows something analysts don't. Or perhaps investors have simply fallen in love with a compelling narrat

Has AI's biggest spending boom just become software's biggest headache? Watching $IBM(IBM)$ suffer its worst one-day share price collapse since records began in 1968 was rather like watching a seasoned marathon runner trip over the finishing tape. Few expected perfection, but almost nobody expected a 25%-plus plunge that erased roughly US$67 billion in market value before the company had even reported quarterly earnings. Yet I think the market may be asking the wrong question. The debate isn't simply whether IBM's AI turnaround has failed. It's whether the AI investment cycle itself has temporarily turned against the very software companies expected to benefit from it. That sounds absurd until you consider IBM's explanation. Enterprise customers ha

When Wall Street Can't Even Agree on Reality Every so often I come across a stock where the numbers tell one story and investors tell another. $Paramount Skydance Corp(PSKY)$ is one of those rare occasions. The company is covered by 27 analysts, yet only 52% rate it a Buy. That is effectively a coin toss for a company of this size. Even more striking, price targets range from just $2 to $20 a share, while the average target has quietly fallen by almost 10% over the past three months. That isn't normal disagreement over valuation. It's a disagreement over what Paramount Skydance will actually become. For me, that's what makes this one of the most fascinating investments in today's market. Investors aren't simply debating earnings; they're debating

Inside $Summit Therapeutics PLC(SMMT)$ $15 Billion Leap of Faith Every bull market eventually produces a stock that stops behaving like a company and starts behaving like a referendum. Right now, that stock may be Summit Therapeutics. On one side sit investors convinced ivonescimab is the most important oncology breakthrough in years. On the other are sceptics who see a company worth billions despite having virtually no commercial revenue and a single regulatory hurdle capable of changing everything overnight. The truth is that both camps have a point. And that is precisely why Summit has become one of Wall Street's most fascinating battlegrounds. Wall Street is pricing probabilities, not profits The Drug That Started the Argument Summit's investm

For years, the investment debate around Ford was tediously predictable. Was it simply a cheap legacy carmaker? Could it survive the EV transition? Would Detroit ever catch Tesla? Then, seemingly overnight, Ford threw the script out of the window and wandered into one of the hottest investment themes on the planet: powering artificial intelligence. The timing is no coincidence. Wall Street is quietly undergoing a dramatic rotation away from parts of enterprise software, where investors increasingly fear AI agents will erode traditional seat-based licensing models. Capital is instead flooding towards the physical infrastructure required to make AI work: power generation, cooling, transmission and energy storage. Ford didn't create that shift, but it may have recognised it earlier than most l

Every so often the market serves up a stock that resembles a Rorschach test. Some investors see tomorrow's financial infrastructure. Others see an overvalued middleman living on borrowed time. Right now, Circle Internet is that stock. Every moat begins as someone else's commodity The latest catalyst was dramatic. Reports that Visa, Mastercard, Stripe, BlackRock and Coinbase are backing the rival Open USD stablecoin knocked more than 17% off Circle's share price in a single session. Yet the analyst reaction was almost surreal. Compass Point cut its price target to US$55, while William Blair maintained a remarkable US$650 valuation, arguing the market had overreacted to competitive fears. When respected analysts looking at exactly the same company disagree by almost 1,100%, the real debate i

When everyone disagrees, I start paying closer attention There is something oddly comforting about consensus. Markets love neat stories, tidy valuations and analyst price targets that huddle together like penguins in a snowstorm. SanDisk is offering none of that. Instead, it has become one of the market's biggest arguments. Within days, one major analyst dramatically lifted their price target by around 76%, while others remained considerably more cautious. Depending on whose spreadsheet I open, SanDisk is either one of the most compelling AI infrastructure investments available or an expensive memory manufacturer riding the latest technology wave before gravity inevitably returns. That disagreement, rather than the share price itself, is what makes SanDisk fascinating today. Wall Street ag

Wall Street Is Measuring the Wrong Turnaround I think Wall Street is asking the wrong question about $Nike(NKE)$. Investors remain fixated on quarterly earnings, margins and revenue beats, yet this is no longer a conventional earnings story. It is a distribution story. That distinction matters. A company can repair a balance sheet in months, but rebuilding an ecosystem of retailers, athletes and consumers after years of strategic missteps is far slower. Trust is not reported every quarter, yet it often determines whether future earnings recover at all. Nike's share price, hovering around levels last seen more than a decade ago, reflects widespread scepticism that the turnaround will succeed. I believe the market is using a scorecard that captures t

The Market Is Pricing Earnings. I Think Washington Is Pricing Permission. For years, investing in UnitedHealth felt almost reassuringly straightforward. The company combined scale, disciplined execution and an unmatched healthcare ecosystem into a machine that compounded earnings with remarkable consistency. Investors debated medical cost trends, margins and valuation multiples, but rarely questioned whether the business model itself would remain politically acceptable. That assumption deserves far more scrutiny today. Healthcare still works. Permission is becoming the scarce asset I think the real investment debate has quietly migrated from earnings power to something much harder to model: political licence. Investors continue to ask how quickly UnitedHealth can restore profitability afte

When Efficiency Stops Looking Like Growth For years, Block seemed to be starring in two entirely different films. In one, it was an innovative fintech reshaping commerce through Square and Cash App. In the other, it was an unfocused pandemic darling distracted by Bitcoin, the costly Afterpay acquisition and the unconventional leadership of Jack Dorsey. Neither story quite reflected what was quietly happening beneath the surface. To me, Block has evolved into something that the market still struggles to recognise. Rather than being primarily a payments company, it is steadily becoming an efficiency platform whose economics improve almost invisibly. That distinction matters because invisible competitive advantages rarely command premium valuations until they have already compounded for years

Why I Think Walmart’s Real Product Is the Customer Investors have become fascinated by Walmart’s advertising business. Every earnings season seems to produce another discussion about retail media, digital ads and whether Walmart Connect can become the next great profit engine. I think the market is staring at the wrong shelf. Advertising matters, but it is merely one expression of a much larger advantage. Walmart’s true asset is its ability to earn multiple streams of income from a single customer interaction. A family that enters a store to buy milk can also become a marketplace customer, a Walmart+ subscriber, a delivery user and an advertising target, all before the trolley reaches the car park. The shopping trolley is quietly becoming a multi-product platform. One trolley. Several busi

The Balance Sheet Behind the Fairy Tale For years, investors have treated Disney as though streaming was the only story worth following. I think that misses the bigger plot entirely. The real investment case no longer revolves around whether Disney+ can make money — it already has. Instead, I believe Disney's future valuation depends on something far less glamorous but infinitely more important: how management allocates capital. That may not inspire a theme park ride, but it is precisely how shareholder wealth is created. At roughly US$102 per share, Disney trades on a trailing price-to-earnings ratio of around 16 and a forward multiple below 14. Those are hardly the valuations of a company that owns some of the world's most valuable intellectual property. Yet the market continues to treat

The Fleet That Never Stops Paying Most investors still value ASML by asking a simple question: how many EUV machines will it ship next quarter? I think they are asking the wrong question. The real investment story begins after those machines leave the factory. Every lithography system entering production quietly expands an installed ecosystem requiring software upgrades, field servicing, productivity enhancements and process optimisation throughout its working life. Rather than behaving like a conventional capital equipment manufacturer, ASML is increasingly resembling the owner of an industrial platform whose economics improve with age. Gravity rarely announces itself until escape becomes impossible Platforms compound differently from products. That distinction matters because Wall Street